Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Evaluation of the Effects of Photodynamic Therapy Consisted of the Blue Laser and Zinc Oxide Qds on Mda-Mb-231 Cancer Cells by Inhibiting Cancer Markers and Inducing Apoptosis Publisher Pubmed



Javani Jouni F1 ; Rastegarpouyani N2 ; Najjar N3 ; Nasirpour M4 ; Payez A5 ; Kashi G6, 7 ; Zafari J8
Authors

Source: Lasers in Medical Science Published:2024


Abstract

The increasing number of cancer patients has cast attention on developing new anti-cancer modalities. Photodynamic therapy is a safe anti-cancer approach, which encompasses (1) local administration of a photosensitizer and (2) light irradiation. Zinc oxide (ZnO) quantum dots (QDs) are photosensitizers that can be utilized for this purpose. In the present study, to better appreciate the likely more efficient cytotoxic effect of the combination of ZnO QDs and the visible 470-nm blue light in comparison to the QDs alone, several assays were to be conducted upon breast cancer MDA-MB 231 cells. MTT assay showed that in certain groups the combination displayed higher cytotoxic effects compared to those following QD treatment alone. LDH leakage and lipid peroxidation rates by the combination were significantly higher than treatment with either the blue laser or QDs. Although the combination managed to meaningfully reduce the number of colonies and CAT activity compared to QD treatment, there were no palpable differences between them. Lastly, the combination was able to increase the apoptotic genes, including BAX, TP53, caspase 3, and caspase 9 compared to QD, while, in the case of Bcl-2, an anti-apoptotic gene, none of the groups managed to make any tangible differences on its expression levels. Our findings propose that there may be synergistic effects between the blue laser and QD that can possibly be adopted in anti-cancer therapy in the future. However, further investigations regarding this matter are of the essence. © 2024, The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.
Other Related Docs
4. Overcoming Cisplatin’S Challenges: A Promising Future in Cancer Care; a Comprehensive Review, International Journal of Medical Toxicology and Forensic Medicine (2023)
12. Application of Nano-Radiosensitizers in Combination Cancer Therapy, Bioengineering and Translational Medicine (2023)
19. Photodynamic Therapies for Cancer Treatment, Cancer Targeting Therapies: Conventional and Advanced Perspectives (2023)